NEW YORK, Dec 29 – Paradigm genetics has licensed the Rosetta Resolver gene expression analysis system from Rosetta Inpharmatics and Agilent Technologies, the companies announced Friday.
The companies did not disclose the financial terms of the agreement. Agilent has been the exclusive distributor of the Rosetta Resolver, a bioinformatics gene expression analysis system that can be used with a variety of microarrays, since December 1999.
Rosetta has previously licensed the Resolver, which it launched in its newest version October 3, to Glaxo Wellcome and the Harvard Center for Genomics Research. Rosetta also recently opened a new gene expression profiling facility in Bothell, Wash.